Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of extract of Unaudited Financial Results for the Quarter and nine Months ended on 31st December, 2023.19-02-2024
19-02-2024
Earum Pharmaceuticals Ltd - 542724 - Extract Of Board Meeting Held On Wednesday, 14Th February, 2024
Extract of Board Meeting held on Wednesday, 14th February, 2024 as per attachment.14-02-2024
Earum Pharmaceuticals Ltd - 542724 - Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December, 2023 Along With Limited Review Report
Submission of Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2023 along with Limited Review Report as per attachment.14-02-2024
Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 14Th February, 2024
Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 14th February, 2024 at the Registered Office of the Company which commenced at 4:00 P.M. and concluded at 5:50 P.M. inter-alia has, considered and approved agendas as per attachments.14-02-2024
Earum Pharmaceuticals Ltd - 542724 - Intimation Pertaining To Requests Received For Reclassification Of Shareholding From 'Promoter And Promoter Group' Category To 'Public' Category As Per Regulation 31A Of SEBI (LODR) Regulations, 2015
Intimation pertaining to request received for Reclassification of shareholding from "Promoter and Promoter Group" Category to "Public" Category as per regulation 31A of SEBI (LODR) Regulation, 201514-02-2024
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Announcement under regulation 30 (LODR), Resignation of the Chief Financial Officer Officer of the Company10-02-2024
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Directorate
Announcement under regulation 30 (LODR) - Appointment of CFO09-02-2024
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
Announcement under Regulation 30 (LODR) - Change in Corporate Address09-02-2024
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Announcement under Regulation 30 (LODR), 2015 - Change in Registered office Address09-02-2024
Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 9th February, 2024 at A-1311, Sun West Bank, Ashram Road, Ahmedabad - 380 009, Which was commenced at 6:00 P.M. and concluded at 7:30 P.M. inter-alia has, considered and approved: 1. Change the Register office of the Company from S.F. Shop - 3/2/B Samruddhi Residency, Raspan Arcade, Cross Road, Nr. Satyam Complex, Nikol, Ahmedabad - 382 350 to A-1311, Sun West Bank, Ashram Road, Ahmedabad - 380 009 w.e.f. 9th February, 2024. 2. To keep books of account and other relevant books and papers and financial statements at A-1311, Sun West Bank, Ashram Road, Ahmedabad - 380 009 w.e.f. 9th February, 2024. 3. Appointment of Mr. Vaghasiya Brijeshkumar Mathurbhai as Chief Financial Officer of the Company w.e.f. 9th February, 2024.09-02-2024